| 5.82 0.06 (1.04%) | 09-13 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.39 | 1-year : | 8.88 |
| Resists | First : | 6.33 | Second : | 7.61 |
| Pivot price | 6.18  |
|||
| Supports | First : | 4.26 | Second : | 3.55 |
| MAs | MA(5) : | 5.73 |
MA(20) : | 6.25 |
| MA(100) : | 7.85 |
MA(250) : | 10.25 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 15.6 |
D(3) : | 12.4 |
| RSI | RSI(14): 43.1 |
|||
| 52-week | High : | 25.5 | Low : | 4.26 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ RBOT ] has closed above bottom band by 31.8%. Bollinger Bands are 41.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.87 - 5.89 | 5.89 - 5.91 |
| Low: | 5.5 - 5.52 | 5.52 - 5.55 |
| Close: | 5.78 - 5.82 | 5.82 - 5.86 |
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Fri, 06 Sep 2024
Vicarious Surgical COO sells shares worth over $1,100 - Investing.com
Wed, 28 Aug 2024
Vicarious Surgical Inc. (RBOT): Among The Best Medical AI Companies - Insider Monkey
Wed, 21 Aug 2024
Vicarious Surgical to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - StockTitan
Mon, 12 Aug 2024
Vicarious Surgical Reports Second Quarter 2024 Financial Results - OrthoSpineNews
Tue, 11 Jun 2024
Why Vicarious Surgical (RBOT) Stock Is Falling - Benzinga
Mon, 10 Jun 2024
Vicarious Surgical Announces Reverse Stock Split - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 5 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 30.5 (%) |
| Held by Institutions | 35.9 (%) |
| Shares Short | 113 (K) |
| Shares Short P.Month | 86 (K) |
| EPS | -10.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 12.22 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -44.3 % |
| Return on Equity (ttm) | -82.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -12.97 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -54 (M) |
| Levered Free Cash Flow | -31 (M) |
| PE Ratio | -0.58 |
| PEG Ratio | 0 |
| Price to Book value | 0.47 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.57 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|